EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB 1 and Serotonin 5HT 2A Receptors

Minos-Timotheos Matsoukas iD, Marc Ciruela-Jardí iD, Maria Gallo iD, Sergi Ferre iD, David Andreu iD, Vicent Casadó iD, Leonardo Pardo iD, Estefanía Moreno iD

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c01796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Minos-Timotheos Matsoukas und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of West Attica, Ag. Spyridonos, Egaleo 12243, Greece. Hauptthemen laut MEDLINE: Receptor, Cannabinoid, CB1, Receptor, Serotonin, 5-HT2A, Drug Design. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, European Regional Development Fund, Ministerio de Econom?a y Competitividad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Activation of cannabinoid CB1 receptors (CB1R) by agonists induces analgesia but also induces cognitive impairment through the heteromer formed between CB1R and the serotonin 5HT2A receptor (5HT2AR). This side effect poses a serious drawback in the therapeutic use of cannabis for pain alleviation. Peptides designed from the transmembrane helices of CB1R, which are predicted to bind 5HT2AR and alter the stability of the CB1R-5HT2AR heteromer, have been shown to avert CB1R agonist-induced cognitive impairment while preserving analgesia. Using these peptides as templates, we have now designed nonpeptidic small molecules that prevent CB1R-5HT2AR heteromerization in bimolecular fluorescence complementation assays and the heteromerization-dependent allosteric modulations in cell signaling experiments. These results provide proof-of-principle for the design of optimized ligand-based disruptors of the CB1R-5HT2AR heteromer, opening new perspectives for in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Cannabinoid, CB1Receptor, Serotonin, 5-HT2ADrug DesignLigandsHumansHEK293 CellsProtein MultimerizationStructure-Activity RelationshipAnimalsSmall Molecule Libraries

Substanzen

Receptor, Cannabinoid, CB1LigandsReceptor, Serotonin, 5-HT2ASmall Molecule Libraries

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of West Attica, Ag. Spyridonos, Egaleo 12243, Greece.
  • Laboratori de Medicina Computacional, Unitat de Bioestadística, Facultat de Medicina, Universitat Autónoma de Barcelona, Bellaterra 08193, Spain.
  • Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, Institute of Biomedicine of the University of Barcelona (IBUB),University of Barcelona, Barcelona 08028, Spain.
  • Department of Medicine and Life Sciences (MELIS-UPF), Universitat Pompeu Fabra, Barcelona 08003, Spain.
  • Integrative Neurobiology Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes of Health, Baltimore, Maryland 21224, United States.

ORCID-Profile: Minos-Timotheos Matsoukas, Marc Ciruela-Jardí, Maria Gallo, Sergi Ferre, David Andreu, Vicent Casadó, Leonardo Pardo, Estefanía Moreno

Förderung

  • Intramural NIH HHS
  • European Regional Development Fund
  • Ministerio de Econom?a y Competitividad
  • National Institute on Drug Abuse
  • Generalitat de Catalunya
  • Ministerio de Ciencia e Innovaci?n

Zitieren

APA

Matsoukas, M. T., Ciruela-Jardí, M., Gallo, M., Ferre, S., Andreu, D., Casadó, V., Pardo, L., & Moreno, E. (2025). Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB 1 and Serotonin 5HT 2A Receptors. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01796

Vancouver

Matsoukas MT, Ciruela-Jardí M, Gallo M, Ferre S, Andreu D, Casadó V, et al. Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB 1 and Serotonin 5HT 2A Receptors. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01796

BibTeX
@article{Matsoukas2025,
  author = {Matsoukas, Minos-Timotheos and Ciruela-Jardí, Marc and Gallo, Maria and Ferre, Sergi and Andreu, David and Casadó, Vicent and Pardo, Leonardo and Moreno, Estefanía},
  title = {Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB 1 and Serotonin 5HT 2A Receptors},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c01796}
}
Kostenlos starten →